Latka logo
Adragos logo

Adragosrevenue & acquisition

Munich, Bavaria, GermanyFounded 2020

Adragos was acquired.

Adragos Pharma is a globally operating Contract Development and Manufacturing Organisation (CDMO) focused on the development and manufacturing of drug products (FDF) in the small molecule segment.

adragos-pharma.comLinkedInUpdated Oct 14, 2026
Annual revenue
$74.6M
Sep 2024EST
Owner
Undisclosed
Date not on record

Adragos revenue

Adragos has not published its revenue. Growjo puts it at about $74.6M a year (September 2024).

$0
$20M
$40M
$60M
$0
–
$74.6M
20202021–232024
ReportedEstimateFounded 2020 at $0; every reading has its own bar
As ofRevenueSource
Sep 2024$74.6MESTGrowjo estimate

Who owns Adragos

Another company owns Adragos. The date and price of the deal are not on record.

Adragos team

Categories

How this page is sourced

1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Oct 14, 2026Data disclaimerReport a correctionClaim this profileRun Adragos? Join the podcast